引用本文: |
何江江,胡善联,汤真清,等.上海市血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂治疗原发性高血压的经济学评价研究[J].中国卫生经济,2016,(7):80-84.[点击复制] |
.Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension: A Case Study of Shanghai[J].CHINESE HEALTH ECONOMICS,2016,(7):80-84.[点击复制] |
|
摘要: |
|
关键词: |
DOI: |
|
基金项目: |
|
Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension: A Case Study of Shanghai |
|
() |
Abstract: |
|
Key words: |